Jun
2026
Pennsylvania Convention Center, Philadelphia
Visit us
stand 531

Dow Development Labs LLC

Exhibitor at CPHI Americas 2026
About Us

Liquid and semi-solid drug products are our core expertise. Dow Development Laboratories develops, manufactures, packages and tests topical semi-solid and liquid oral products for clinical use. Products are designed to be disease-compatible, cosmetically elegant & stable, and are filled, packaged & labeled in house and distributed to clinical sites. Our formulation, analytical, production, quality, & clinical labeling teams have decades of experience moving products quickly toward regulatory approval, as does parent company, Symbio, a clinical CRO.

  • Country/Region:
    United States
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
CMO/CDMO
Primary activities
Contract Research Organisation
Contact info
  • 1031 North McDowell Boulevard, 94954, Petaluma, California, United States
Event information
CPHI Americas 2026
  • 2 Jun 2026 - 4 June 2026
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 531

Dow Development Labs LLC Resources (1)